Menu
GeneBe

chr12-64694859-G-T

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_178169.4(RASSF3):​c.664G>T​(p.Ala222Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000246 in 1,461,884 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.000025 ( 0 hom. )

Consequence

RASSF3
NM_178169.4 missense

Scores

1
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.62
Variant links:
Genes affected
RASSF3 (HGNC:14271): (Ras association domain family member 3) The RAS oncogene (MIM 190020) is mutated in nearly one-third of all human cancers. Members of the RAS superfamily are plasma membrane GTP-binding proteins that modulate intracellular signal transduction pathways. A subfamily of RAS effectors, including RASSF3, share a RAS association (RA) domain.[supplied by OMIM, Jul 2003]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.06395036).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
RASSF3NM_178169.4 linkuse as main transcriptc.664G>T p.Ala222Ser missense_variant 5/5 ENST00000542104.6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
RASSF3ENST00000542104.6 linkuse as main transcriptc.664G>T p.Ala222Ser missense_variant 5/51 NM_178169.4 P2Q86WH2-1
RASSF3ENST00000637125.1 linkuse as main transcriptc.847G>T p.Ala283Ser missense_variant 6/65 A2
RASSF3ENST00000283172.8 linkuse as main transcriptc.*153G>T 3_prime_UTR_variant, NMD_transcript_variant 4/42 Q86WH2-2

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD3 exomes
AF:
0.0000875
AC:
22
AN:
251390
Hom.:
0
AF XY:
0.0000736
AC XY:
10
AN XY:
135860
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00114
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000246
AC:
36
AN:
1461884
Hom.:
0
Cov.:
31
AF XY:
0.0000206
AC XY:
15
AN XY:
727246
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000831
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.0000497
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.0000189
ExAC
AF:
0.0000659
AC:
8

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMay 27, 2022The c.664G>T (p.A222S) alteration is located in exon 5 (coding exon 5) of the RASSF3 gene. This alteration results from a G to T substitution at nucleotide position 664, causing the alanine (A) at amino acid position 222 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.083
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.61
CADD
Benign
18
DANN
Benign
0.58
Eigen
Benign
-0.28
Eigen_PC
Benign
-0.17
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Benign
0.79
T;T;.
M_CAP
Benign
0.012
T
MetaRNN
Benign
0.064
T;T;T
MetaSVM
Benign
-1.0
T
MutationTaster
Benign
0.93
D;D
PrimateAI
Benign
0.32
T
Polyphen
0.024
.;B;B
Vest4
0.17, 0.11
MutPred
0.29
.;Gain of phosphorylation at A222 (P = 0.0181);Gain of phosphorylation at A222 (P = 0.0181);
MVP
0.18
MPC
0.067
ClinPred
0.029
T
GERP RS
3.7
Varity_R
0.057
gMVP
0.20

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs766150447; hg19: chr12-65088639; API